Skip to main content

Table 4 FIQL domain scores by visit and pre–post differences (all patients, ITT)

From: Skeletal muscle-derived cell implantation for the treatment of sphincter-related faecal incontinence

  V-2 V0 V2 V3 V4
By visit, mean (SD)
 Lifestyle 2.1 (0.71) 2.2 (0.72) 3.2 (0.77) 3.3 (0.69) 3.4 (0.77)
 Coping/behaviour 1.4 (0.34) 1.6 (0.54) 2.7 (0.77) 2.8 (0.86) 3.0 (0.91)
 Depression/perception 2.3 (0.84) 2.2 (0.75) 3.2 (0.72) 3.3 (0.73) 3.3 (0.72)
 Embarrassment 1.4 (0.58) 1.7 (0.66) 2.8 (0.89) 3.0 (0.80) 3.2 (0.84)
    V2 – V0 V3 – V0 V4– V0
Pre–post differences, mean (95% CI)
 Lifestyle    1.0 (0.74; 1.19)* 1.1 (0.92; 1.35)* 1.2 (0.95; 1.46)*
 Coping/behaviour    1.1 (0.83; 1.35)* 1.3 (0.98; 1.55)* 1.4 (1.07; 1.67)*
 Depression/perception    0.9 (0.68; 1.14)* 1.0 (0.77; 1.26)* 1.1 (0.81; 1.33)*
 Embarrassment    1.0 (0.66; 1.29)* 1.2 (0.92; 1.52)* 1.4 (1.11; 1.73)*
  1. FIQL Fecal Incontinence Quality of Life, ITT intention to treat, V visit, V-2 3 months pre implantation, V0 implantation, V2, V3 and V4 1, 6 and 12 months post implantation, SD standard deviation, CI confidence interval
  2. *Significant change from baseline according to 95% CI